[HTML][HTML] прогностическое значение биомаркеров при плоскоклеточном раке полости рта. Обзор литературы
АВ Игнатова, АМ Мудунов… - Опухоли головы и …, 2014 - cyberleninka.ru
Достижения в понимании молекулярных механизмов, лежащих в основе развития
плоскоклеточного рака полости рта (ПРПР), привели к увеличению числа молекул …
плоскоклеточного рака полости рта (ПРПР), привели к увеличению числа молекул …
MMP9, Cyclin D1 and β-Catenin are useful markers of p16-positive squamous cell carcinoma in therapeutic EGFR inhibition in vitro
C Umbreit, P Erben, A Faber, RD Hofheinz… - Anticancer …, 2015 - ar.iiarjournals.org
Background/Aim: In the United States 53,640 new cases of head and neck cancer were
estimated in 2013. Over 95% of these cases were evaluated as squamous cell carcinoma …
estimated in 2013. Over 95% of these cases were evaluated as squamous cell carcinoma …
Identification of differentially expressed proteins from smokeless tobacco addicted patients suffering from Oral squamous cell carcinoma
UU Malik, IA Siddiqui, A Ilyas, Z Hashim… - Pathology & Oncology …, 2020 - Springer
Oral squamous cell carcinoma (OSCC) is the eight most common malignancy worldwide
with an incidence rate of 40% in south-east Asia. Lack of effective diagnostic tools at early …
with an incidence rate of 40% in south-east Asia. Lack of effective diagnostic tools at early …
General Introduction to Head and Neck Cancer: Etiology, Symptoms, Diagnosis, Staging, Prevention, and Treatment
S Kusampudi, N Konduru - Early Detection and Treatment of Head & Neck …, 2021 - Springer
Head and neck cancer (HNC) is a term used for cancers originating from lip and oral cavity,
salivary glands, nasopharynx, oropharynx, hypopharynx, and larynx. The global incidence of …
salivary glands, nasopharynx, oropharynx, hypopharynx, and larynx. The global incidence of …
[HTML][HTML] Induction chemotherapy plus nimotuzumab followed by concurrent chemoradiotherapy for advanced nasopharyngeal carcinoma
X Song, S Wang, J Li, L Yan, F Chen… - Archives of Medical …, 2021 - ncbi.nlm.nih.gov
Results With a median follow-up of 61.4 months (range: 1.7–96.5 months), the 5-year OS
and PFS for group A vs. groups B+ C were 74.8±4.1% versus 87.0±4.6%(p= 0.043) and …
and PFS for group A vs. groups B+ C were 74.8±4.1% versus 87.0±4.6%(p= 0.043) and …
[PDF][PDF] Epidermal Growth Factor Receptor: Prognostic Marker For Undifferentiated Nasopharynx Carcinomas North-African Patients
E Kerboua, C Rancoule, N Magné… - IOSR Journal of Dental …, 2024 - hal.science
Epidermal growth factor receptor (EGFR) is overexpressed in many different cancers and is
involved in the regulation of cellular metabolism, growth, migration and differentiation. EGFR …
involved in the regulation of cellular metabolism, growth, migration and differentiation. EGFR …
[HTML][HTML] Nuclear expression of p65 (RelA) in patients receiving post-operative radiotherapy for locally advanced squamous cell carcinoma of the head and neck
D Rades, S Huttenlocher, ND Seibold, MP Gebhard… - BMC cancer, 2015 - Springer
Background This study investigated the prognostic role of nuclear expression of p65 in
patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN) …
patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN) …
Rapid detection and destruction of squamous cell carcinoma of the head and neck by nano‐quadrapeutics
EY Lukianova–Hleb, DO Lapotko - Head & Neck, 2015 - Wiley Online Library
Survival and quality of life remain poor for patients with head and neck squamous cell
carcinoma (HNSCC) that cannot be fully resected safely, and form therapy‐resistant residual …
carcinoma (HNSCC) that cannot be fully resected safely, and form therapy‐resistant residual …